Evidence map›Paper›PMID 37760513›Full record

ArticleCancers2023

Midline Gliomas: A Retrospective Study from a Cancer Center in the Middle East.

Sarah Al Sharie, Dima Abu Laban, Jamil Nazzal, Shahad Iqneibi, Sura Ghnaimat, Abdallah Al-Ani, Maysa Al-Hussaini

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Frequency and outcomes of midline gliomas in a tertiary care hospital in Pakistan: a retrospective study.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sarah Al SharieFaculty of Medicine, Yarmouk University, Irbid 21163, Jordan.ORCID 0000-0002-8004-0963
Dima Abu LabanDepartment of Radiology, King Hussein Cancer Center, Amman 11941, Jordan.
Jamil NazzalOffice of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan.
Shahad IqneibiOffice of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan.ORCID 0000-0002-0826-4954
Sura GhnaimatOffice of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan.
Abdallah Al-AniOffice of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan.ORCID 0000-0002-3517-3601
Maysa Al-HussainiDepartment of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman 11941, Jordan.ORCID 0000-0001-6392-150X
King Hussein Cancer Center · JOYarmouk University · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Midline gliomas are tumors that occur in midline structures and can be circumscribed or diffuse. Classical midline structures include the thalamus, brainstem, and spinal cord. Other midline structures include the corpus callosum, basal ganglia, ventricles, paraventricular structures, and cerebellum. Diffuse midline glioma (DMG) is a diffuse glioma that occurs in the classical midline structures, characterized by a specific genetic alteration, and associated with grim outcome. This study was conducted at King Hussein Cancer Center and reviewed the medical records of 104 patients with circumscribed and diffuse gliomas involving midline structures that underwent biopsy between 2005 and 2022. We included a final cohort of 104 patients characterized by a median age of 23 years and a male-to-female ratio of 1.59-to-1. Diffuse high-grade glioma (DHGG) was the most common pathological variant (41.4%), followed by DMG (28.9%). GFAP was positive in most cases (71.2%). Common positive mutations/alterations detected by surrogate immunostains included H3 K27me3 (28.9%), p53 (25.0%), and H3 K27M (20.2%). Age group, type of treatment, and immunohistochemistry were significantly associated with both the location of the tumor and tumor variant (all;

Indexed as

brainstemcircumscribed gliomacorpus callosumdiffuse midline glioma (DMG)H3 K27me3 alterationH3 K27M mutationspinal cordthalamus

Identifiers

PMID37760513
PMCPMC10527416
OpenAlexW4386748391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.